Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer

PaperCitations, authors & open-access status

CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 88 citations, 2020 year and gold oa status.

88
Citations
2020
Year
gold
OA Status

Related on ScholarIQ

Rui Meng
Author
Cancer-related Molecular Pathways
Topic
Cancer-related Molecular Pathways
Topic
Genetics and Neurodevelopmental Disorders
Topic
Epigenetics and DNA Methylation
Topic
470M+ articles · free account